Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 30, 2015 6:36 AM ET

Biotechnology

Company Overview of Spark Therapeutics, Inc.

Executive Profile

Steven M. Altschuler M.D.

Chairman and Member of Nominating & Corporate Governance Committee, Spark Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 4 different industries.

See Board Relationships
62--

Background

Dr. Steven M. Altschuler, M.D., served as the Chief Executive Officer of The Children's Hospital of Philadelphia from April 2000 to July 1, 2015 and served as its President. Dr. Altschuler joined Children's Hospital in 1982 as a Fellow in the Division of Pediatric Gastroenterology and Nutrition. Dr. Altschuler was the Physician-in-Chief and the first holder of the Leonard and Madlyn Abramson Endowed Chair in Pediatrics at CHOP and professor and chair of the Department ...

Corporate Headquarters

3737 Market Street
Philadelphia, Pennsylvania 19104

United States

Phone: 888-772-7560
Fax: --

Board Members Memberships

2009-Present
Director, Chairman of Nutrition Science & Technology Committee and Member of Compensation & Management Development Committee
2012-Present
Director, Member of Audit Committee and Member of Compensation & Benefits Committee
2013-Present
Chairman and Member of Nominating & Corporate Governance Committee

Education

BA
Case Western Reserve University
MD
Case Western Reserve University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Edward O. Lanphier IIFounder, Chief Executive Officer, President, Director and Member of Clinical Review Committee
Sangamo Biosciences Inc.
$650.0K
Jörn Aldag Chief Executive Officer, Managing Director and Member of Management Board
uniQure N.V.
$484.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Spark Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.